{"transactions":[{"id":709456,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-07-15T01:00:51.000Z","date":"2026-07-13","kind":"grant","planned":false,"acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan. Option will vest as to 1/4th of the total number of shares subject to the option on the one-year anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":1650000,"derivative":{"exercise_price":0.8365,"exercise_date":"2027-07-13","expiration_date":"2036-07-12","underlying":"Common Stock","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001193125-26-303681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526303681/ownership.xml","form_type":"4"}},{"id":819823,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-04-02T22:00:21.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":340900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":340900,"derivative":{"exercise_price":6.03,"expiration_date":"2036-04-01","underlying":"Class A Ordinary Shares","underlying_shares":340900},"source":{"system":"sec-edgar","filing":"0001966926-26-000002","document":"form4-04022026_060416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000196692626000002/form4-04022026_060416.xml","form_type":"4"}},{"id":1085620,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-07-17T21:20:07.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":672000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on July 7, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":672000,"derivative":{"exercise_price":1.3,"expiration_date":"2035-07-15","underlying":"Class A Ordinary Shares","underlying_shares":672000},"source":{"system":"sec-edgar","filing":"0001415889-25-019965","document":"form4-07172025_090704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925019965/form4-07172025_090704.xml","form_type":"4"}},{"id":1182555,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/35th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vest in equal monthly installments over the following thirty-four (34) months, subject to the reporting person's continuous service."}],"balance_after":2656,"derivative":{"exercise_price":97.75,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":8961},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182554,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":97.75,"exercise_date":"2023-04-01","expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182553,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/35th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vest in equal monthly installments over the following thirty-four (34) months, subject to the reporting person's continuous service."}],"balance_after":160,"derivative":{"exercise_price":255.25,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":543},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182552,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":255.25,"exercise_date":"2023-04-01","expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182551,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/23rd of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following twenty-two (22) months, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"exercise_price":427.63,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182550,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":427.63,"exercise_date":"2023-04-01","expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":381},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182549,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/11th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following ten (10) months, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"exercise_price":303.75,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":154},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182548,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":303.75,"exercise_date":"2023-04-01","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":496},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182547,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":961.75,"exercise_date":"2023-02-06","expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":460},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1182546,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"other":true,"other_text":"Former EVP, CFO & COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-02T23:54:05.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration."}],"balance_after":0,"derivative":{"exercise_price":996.25,"exercise_date":"2022-08-20","expiration_date":"2025-09-03","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0000905148-25-001058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001058/form4.xml","form_type":"4"}},{"id":1221643,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO and COO"}}],"security":"Common Stock","published_at":"2025-03-05T22:17:42.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":1211,"price":6.997,"value":8473.367,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":56231,"source":{"system":"sec-edgar","filing":"0000905148-25-000864","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825000864/form4.xml","form_type":"4"}},{"id":1291659,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO and COO"}}],"security":"Common Stock","published_at":"2025-01-29T21:52:53.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":34050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following January 27, 2025, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares subject to the RSUs shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":57442,"source":{"system":"sec-edgar","filing":"0000905148-25-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825000245/form4.xml","form_type":"4"}},{"id":1356914,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO and COO"}}],"security":"Common Stock","published_at":"2024-11-20T23:04:59.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":1364,"price":11.198,"value":15274.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 18, 2024 and November 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":23392,"source":{"system":"sec-edgar","filing":"0000905148-24-003242","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824003242/form4.xml","form_type":"4"}},{"id":1427312,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:12.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":29,"price":6.631,"value":192.299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":24756,"source":{"system":"sec-edgar","filing":"0000905148-24-002303","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002303/form4.xml","form_type":"4"}},{"id":1427311,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:12.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1041,"price":6.629,"value":6900.789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024."}],"balance_after":24785,"source":{"system":"sec-edgar","filing":"0000905148-24-002303","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002303/form4.xml","form_type":"4"}},{"id":1508565,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-05-21T00:33:28.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":28648,"price":0.617,"value":17675.816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":645671,"source":{"system":"sec-edgar","filing":"0000905148-24-001558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824001558/form4.xml","form_type":"4"}},{"id":1590816,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-03-06T23:17:15.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":5217,"price":0.72,"value":3756.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":674319,"source":{"system":"sec-edgar","filing":"0000905148-24-000908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824000908/form4.xml","form_type":"4"}},{"id":1590815,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-03-06T23:17:15.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":1462,"price":0.721,"value":1054.102,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":679536,"source":{"system":"sec-edgar","filing":"0000905148-24-000908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824000908/form4.xml","form_type":"4"}},{"id":1682292,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"EVP, CFO"}}],"security":"Common Stock","published_at":"2024-01-09T21:40:31.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following January 8, 2024, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":680998,"source":{"system":"sec-edgar","filing":"0000905148-24-000112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824000112/form4.xml","form_type":"4"}},{"id":1734198,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-11-20T22:29:48.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":11958,"price":0.389,"value":4651.662,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":205998,"source":{"system":"sec-edgar","filing":"0000905148-23-001509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514823001509/form4.xml","form_type":"4"}},{"id":1801582,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-08-18T22:25:27.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":1778,"price":1.654,"value":2940.812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":217956,"source":{"system":"sec-edgar","filing":"0001140361-23-040564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123040564/form4.xml","form_type":"4"}},{"id":1801581,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-08-18T22:25:27.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":6408,"price":1.652,"value":10586.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":219734,"source":{"system":"sec-edgar","filing":"0001140361-23-040564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123040564/form4.xml","form_type":"4"}},{"id":1886447,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-05-19T00:17:16.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":1719,"price":2.038,"value":3503.322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":226142,"source":{"system":"sec-edgar","filing":"0001140361-23-025558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123025558/form4.xml","form_type":"4"}},{"id":1886446,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"officer":true,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-05-19T00:17:16.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":6199,"price":2.037,"value":12627.363,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":227861,"source":{"system":"sec-edgar","filing":"0001140361-23-025558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123025558/form4.xml","form_type":"4"}}]}